Ostrum Asset Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$274K Buy
1,026
+640
+166% +$173K 0.02% 459
2025
Q4
$96.8K Sell
386
-129
-25% -$34.3K ﹤0.01% 522
2025
Q3
$148K Sell
515
-5,786
-92% -$1.55M 0.01% 516
2025
Q2
$1.65M Sell
6,301
-6,305
-50% -$1.54M 0.08% 221
2025
Q1
$2.93M Buy
12,606
+2,876
+30% +$698K 0.15% 121
2024
Q4
$2.23M Buy
9,730
+630
+7% +$145K 0.19% 170
2024
Q3
$2.03M Sell
9,100
-15,803
-63% -$3.47M 0.17% 214
2024
Q2
$5.07M Sell
24,903
-502
-2% -$102K 0.44% 42
2024
Q1
$5.55M Buy
25,405
+322
+1% +$70.9K 0.44% 40
2023
Q4
$5.7M Buy
25,083
+3,946
+19% +$829K 0.5% 36
2023
Q3
$4.25M Sell
21,137
-2,525
-11% -$533K 0.39% 54
2023
Q2
$4.91M Buy
23,662
+8,038
+51% +$1.56M 0.41% 57
2023
Q1
$3.08M Buy
+15,624
New +$3.22M 0.27% 119

Other funds holding LH

Ostrum Asset Management's LH Position: Q1 2026 in Review

Ostrum Asset Management increased its Labcorp (LH) stake by 166% in Q1 2026, buying an estimated $173K and bringing the position to 1,026 shares worth $274K. The position accounts for 0.02% of the portfolio, ranked #459.

Ostrum Asset Management first reported a position in LH in Q1 2023 and has held it in 13 quarters since. The position peaked at $5.7M in Q4 2023. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Ostrum Asset Management held 1,026 shares of Labcorp worth $274K as of Q1 2026.
  • Ostrum Asset Management bought 640 Labcorp shares in Q1 2026, an estimated $173K.
  • Labcorp made up 0.02% of Ostrum Asset Management's portfolio in Q1 2026, its #459 holding.
  • Ostrum Asset Management first reported a position in Labcorp in Q1 2023 and has held it in 13 quarters since.
  • Ostrum Asset Management's Labcorp position peaked at $5.7M in Q4 2023.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Ostrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.